Search results for "Depressive disorder"

showing 10 items of 445 documents

The point prevalence of depression and associated sociodemographic correlates in the general population of Latvia

2013

Abstract Aim To determine the point prevalence of depression in the general Latvian population and to explore the associated sociodemographic characteristics. Methods The study was part of the cross-sectional survey on the general population on substance use in Latvia in 2011. It consisted of face-to-face interviews of a randomised stratified multi-stage probability sample. In total, 4493 persons were included, aged between 15 and 64. To assess depression, the participants were interviewed using the Patient Health Questionnaire-9; a score of ≥10 was defined as indicating the presence of a depressive episode. Socio-demographic, subjective health status and alcohol use were assessed using the…

AdultMaleGerontologyAdolescentCross-sectional studyPopulationPrevalenceLogistic regressionOddsYoung AdultPrevalenceHumansMedicineeducationDepression (differential diagnoses)Depressive Disordereducation.field_of_studyDepressionbusiness.industryAlcohol dependenceMiddle AgedLatviaPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesStructured interviewFemalebusinessDemographyJournal of Affective Disorders
researchProduct

Acceptability, attitudes and knowledge towards Transcranial Magnetic Stimulation (TMS) among psychiatrists in France

2020

Abstract Background Non-invasive brain stimulation techniques are becoming a part of psychiatrists’ therapeutic arsenal. Proof of TMS effectiveness and its indications are becoming clearer. While international recommendations exist, and many countries have already recognized the use of these techniques, the French situation is peculiar since no recommendation has been published by the High Authority of Health. Consequently, those techniques are not reimbursed by the healthcare service, few practitioners are trained, some are criticized for using it, and practices remain very heterogeneous. It is therefore important to investigate what slows down the development of these techniques. The obje…

AdultMaleHealth Knowledge Attitudes Practice[SDV]Life Sciences [q-bio]medicine.medical_treatmentApplied psychologyHigh authorityObservationSample (statistics)behavioral disciplines and activitiesHealth Services Accessibility03 medical and health sciences0302 clinical medicineArts and Humanities (miscellaneous)Variable domainSurveys and QuestionnairesmedicineHumansComputingMilieux_MISCELLANEOUSAgedPsychiatryDepressive DisorderMental DisordersTraining levelMiddle AgedTranscranial Magnetic StimulationProfessional culture030227 psychiatry[SDV] Life Sciences [q-bio]Transcranial magnetic stimulationPsychiatry and Mental healthSocioeconomic FactorsPsychoanalytic TheoryBrain stimulationFemaleFranceHealthcare servicePsychologyL'Encéphale
researchProduct

Hyperthymic temperament may protect against suicidal ideation.

2010

Abstract Background The aim of this study was to investigate the role of hyperthymic temperament in suicidal ideation between a sample of patients with affective disorders (unipolar and bipolar). Method We investigated affective disorders outpatients (unipolar, bipolar I, II and NOS) treated in eleven participating centres during at least a six-month period. DSM-IV diagnosis was made by psychiatrists experienced in mood disorders, using the corresponding modules of the Mini International Neuropsychiatric Interview (MINI). In addition, bipolar NOS diagnoses were extended by guidelines for bipolar spectrum symptoms as proposed by Akiskal and Pinto in 1999. Thereby we also identified NOS III (…

AdultMaleHyperthymic temperamentmedicine.medical_specialtyBipolar DisorderPersonality InventoryPsychometricsmedia_common.quotation_subjectPoison controlSuicidal Ideationmental disordersmedicineHumansBipolar disorderPsychiatryTemperamentSuicidal ideationmedia_commonMini-international neuropsychiatric interviewDepressive Disorder MajorBeck Depression InventoryMiddle Agedmedicine.diseaseCyclothymic DisorderPsychiatry and Mental healthClinical PsychologyMood disordersTemperamentFemalemedicine.symptomPsychologyClinical psychologyJournal of affective disorders
researchProduct

Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology

1985

Abstract Weekly dexamethasone suppression tests (DST) were performed in 19 hospitalized patients with major depressive disorder, endogenous subtype, and who had an abnormal DST at admission. Depression scores (Hamilton Rating Scale) and weight changes were collected by investigators who were blind to the test results. Major findings were: (1) the DST gradually normalized 3–4 weeks prior to full resolution of clinical symptomatology; (2) weight loss was an important patient variable which may have contributed to false positive DST results; however, the positive correlation between changes in DST results and changes in depression scores in all our patients with or without weight loss suggests…

AdultMaleHypothalamo-Hypophyseal Systemmedicine.medical_specialtyBipolar DisorderHydrocortisonePsychometricsEndocrinology Diabetes and MetabolismPituitary-Adrenal SystemDexamethasoneEndocrinologyRating scaleWeight lossInternal medicinemedicineHumansPsychiatryBiological PsychiatryDexamethasoneDepression (differential diagnoses)AgedDepressive DisorderPsychopathologyEndocrine and Autonomic SystemsBody WeightWeight changeMiddle Agedmedicine.diseasePsychiatry and Mental healthMajor depressive disorderFemalemedicine.symptomPsychologyFollow-Up StudiesPsychopathologymedicine.drugPsychoneuroendocrinology
researchProduct

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.

1996

A double-blind, randomized, parallel study in 167 hospitalized patients with major depression and melancholia was conducted to determine if rapidly escalated doses of venlafaxine produced an earlier response, compared with rapidly escalated doses of imipramine. The daily dose of venlafaxine was rapidly increased to 375 mg/day over a five-day period, was maintained at this level for 10 days, and then was reduced to 150 mg/day for the remainder of the study. The imipramine dose was rapidly increased to 200 mg/day over five days and was maintained at this level to the end of the study. The primary efficacy variables were time to response and time to sustained response on the HAM-D and MADRS. N…

AdultMaleImipraminePersonality Inventorymedicine.medical_treatmentVenlafaxineAntidepressive Agents TricyclicImipramineDrug Administration ScheduleDouble blindDouble-Blind MethodMelancholiamedicineHumansBiological PsychiatryDepression (differential diagnoses)Rapid responseChemotherapyDepressive DisorderDose-Response Relationship DrugVenlafaxine HydrochlorideParallel studyMiddle AgedCyclohexanolsPsychiatry and Mental healthTreatment OutcomeAnesthesiaAntidepressive Agents Second-GenerationFemalemedicine.symptomPsychologymedicine.drugJournal of psychiatric research
researchProduct

Subchronic Antidepressant Treatment with Venlafaxine or Imipramine and Effects on Blood Pressure and Heart Rate: Assessment by Automatic 24-Hour Moni…

1996

Venlafaxine is a new nontricyclic antidepressant inhibiting the reuptake of serotonin, noradrenaline, and, to a lesser extent, dopamine without antagonizing cholinergic, histaminergic, or noradrenergic receptors. Significantly, in a first placebo-controlled safety and efficacy study, high doses of venlafaxine increased blood pressure in some study subjects. In order to investigate further the effect of subchronic antidepressant drug treatment on blood pressure and heart rate, the effects of a conventional tricyclic (imipramine) and a structurally different phenethylamine antidepressant (venlafaxine) were compared. Sixteen inpatients with major depression (melancholic type) were treated for …

AdultMaleImipramineVenlafaxine HydrochlorideHemodynamicsBlood PressureVenlafaxineAntidepressive Agents TricyclicImipramineDouble-Blind MethodHeart RateHeart ratemedicineHumansPharmacology (medical)Psychiatric Status Rating ScalesDepressive Disorderbusiness.industryVenlafaxine HydrochlorideGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle AgedCyclohexanolsPsychiatry and Mental healthBlood pressureAnesthesiaCirculatory systemAntidepressive Agents Second-GenerationAntidepressantFemalebusinessmedicine.drugPharmacopsychiatry
researchProduct

Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment

1991

In order to establish the clinical validity of currently used ways of subtyping panic disorder the predictive power of associated current avoidance behaviour and (secondary) major depression for the response to active treatment (alprazolam, imipramine) was tested. The analysis was based on the data from the Cross-National-Collaborative-Panic-Study. Limited support for validity evidenced by predicting drug response was found for grading panic disorder by the severity of avoidance behaviour; patients with panic attacks and agoraphobia are more responsive to imipramine (compared with alprazolam) when using the reduction of the total number of panic attacks (or of spontaneous panic attacks) as …

AdultMaleImipraminemedicine.medical_specialtySocial Environmentbehavioral disciplines and activitiesImipraminelaw.inventionDouble-Blind MethodRandomized controlled triallawmental disordersmedicineHumansPharmacology (medical)PsychiatryAgoraphobiaBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive DisorderAlprazolamPanic disorderPanicGeneral MedicinePrognosismedicine.diseaseAnxiety DisordersPanichumanitiesSubtypingPsychiatry and Mental healthAlprazolamFemalemedicine.symptomPsychologymedicine.drugAgoraphobiaClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated …

2015

Abstract Background Animals show seasonal changes in the endocrine and immune system in response to winter stressors. Even though increased inflammation has been implicated in the pathophysiology of depression, whether immune disorder is a key mediator in seasonal affective depression (SAD) is unknown. Here, we hypothesized that short photoperiods in winter may induce inflammatory response, which contributes to SAD, and that light treatments should normalize immune function and improve depressive symptoms. Methods Twenty patients with a diagnosis of SAD, and a score on the HAM-29 of 20 or higher were recruited for this study. Twenty-one healthy subjects with no personal and family history o…

AdultMaleLight therapymedicine.medical_specialtymedicine.medical_treatmentLymphocyteLymphocyte proliferationProinflammatory cytokineInterferon-gammaInternal medicinemedicineAnimalsHumansLymphocytesInflammationAnalysis of VarianceTumor Necrosis Factor-alphaSeasonal Affective DisorderPhototherapymedicine.diseasePsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureCytokineEndocrinologyImmunologyCytokinesMajor depressive disorderFemaleImmune disorderPsychologyHypothalamic–pituitary–adrenal axisInterleukin-1Journal of Affective Disorders
researchProduct

Attentional Biases and Vulnerability to Depression

1999

This study was designed to examine selective processing of emotional information in depression. It focuses on possible attentional biases in depression, and whether such biases constitute a cognitive vulnerability factor to suffer from the disorder or, on the contrary, they reflect a feature associated exclusively with the clinical level of depression. 81 participants were included in the study: 15 with a diagnosis of Major Depression; 17 were diagnosed as Dysthymia; 11 participants scored over 18 in the Beck Depression Inventory (Beck, Rush, Shaw, & Emery, 1979); 15 participants, in whom a sad mood state was induced by an experimental mood induction (Velten technique + music, or biographic…

AdultMaleLinguistics and LanguageAdolescentPersonality InventoryVulnerabilityUNESCO::PSICOLOGÍA::PatologíaAttentional biasesAttentional biasbehavioral disciplines and activitiesLanguage and LinguisticsDevelopmental psychologymental disordersReaction TimeHumansAttentionGeneral PsychologyDepression (differential diagnoses)Depressive Disorder MajorPsychological TestsCognitive vulnerabilityRecallDepressionSrroop taskBeck Depression InventoryCognitionMiddle AgedDepression; Vulnerability; Attentional biases; Srroop taskCognitive biasSemanticsAffect:PSICOLOGÍA::Patología [UNESCO]FemaleDysthymic DisorderPsychologyStroop effectClinical psychologyThe Spanish Journal of Psychology
researchProduct

Genome-wide association data provide further support for an association between 5-HTTLPR and major depressive disorder.

2013

Abstract Background Dysfunctions of serotonergic neurotransmission are supposed to be involved in the pathogenesis of psychiatric disorders such as major depressive disorder (MDD). The concentration of serotonin (5-hydroxytryptamine, 5-HT) in the synaptic cleft is essentially regulated by the 5-HT transporter (5-HTT). A length polymorphism repeat in the 5-HTT promoter region, termed 5-HTTLPR, has been commonly investigated for an association with psychiatric disorders. Methods Genotyping of the 5-HTTLPR is time-consuming and technically challenging. Recently, a two-SNP haplotype was identified that tags the 5-HTTLPR at r 2 =0.775. This allows extraction of 5-HTTLPR genotype information from…

AdultMaleLinkage disequilibriumSynaptic cleftGenotypeSingle-nucleotide polymorphismGenome-wide association studyPolymorphism Single NucleotideGermanygenetics [Haplotypes]mental disordersGenotypegenetics [Serotonin Plasma Membrane Transport Proteins]medicineHumansGenetic Predisposition to Diseaseddc:610GeneticsSerotonin Plasma Membrane Transport ProteinsDepressive Disorder MajorSLC6A4 protein humanHaplotypegenetics [Depressive Disorder Major]Middle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyHaplotypes5-HTTLPRCase-Control Studiesgenetics [Polymorphism Single Nucleotide]Major depressive disorderFemalePsychologyClinical psychologyGenome-Wide Association StudyJournal of affective disorders
researchProduct